EU Fees Revision A ‘Once-In-A-Generation’ Chance To Solve Resource Challenges
Executive Summary
COVID-19 and Brexit have put a great strain on the resources of the EU medicines regulatory system, but the planned review of the EU fee system could produce a system that is more flexible, efficient and better able to respond rapidly to emerging technologies and the needs of health care systems, says EFPIA.